JPWO2020176740A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020176740A5
JPWO2020176740A5 JP2021549970A JP2021549970A JPWO2020176740A5 JP WO2020176740 A5 JPWO2020176740 A5 JP WO2020176740A5 JP 2021549970 A JP2021549970 A JP 2021549970A JP 2021549970 A JP2021549970 A JP 2021549970A JP WO2020176740 A5 JPWO2020176740 A5 JP WO2020176740A5
Authority
JP
Japan
Prior art keywords
item
donor dna
cells
nucleotides
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021549970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521787A5 (https=
JP2022521787A (ja
Publication date
Priority claimed from US16/288,052 external-priority patent/US20200224160A1/en
Application filed filed Critical
Publication of JP2022521787A publication Critical patent/JP2022521787A/ja
Publication of JPWO2020176740A5 publication Critical patent/JPWO2020176740A5/ja
Publication of JP2022521787A5 publication Critical patent/JP2022521787A5/ja
Priority to JP2024219750A priority Critical patent/JP2025061660A/ja
Ceased legal-status Critical Current

Links

JP2021549970A 2018-02-27 2020-02-27 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 Ceased JP2022521787A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024219750A JP2025061660A (ja) 2018-02-27 2024-12-16 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862635702P 2018-02-27 2018-02-27
US16/288,052 2019-02-27
US16/288,052 US20200224160A1 (en) 2018-02-27 2019-02-27 Process for dna integration using rna-guided endonucleases
PCT/US2020/020121 WO2020176740A1 (en) 2018-02-27 2020-02-27 Improved process for dna integration using rna-guided endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024219750A Division JP2025061660A (ja) 2018-02-27 2024-12-16 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法

Publications (3)

Publication Number Publication Date
JP2022521787A JP2022521787A (ja) 2022-04-12
JPWO2020176740A5 true JPWO2020176740A5 (https=) 2023-03-07
JP2022521787A5 JP2022521787A5 (https=) 2023-03-07

Family

ID=71516309

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549970A Ceased JP2022521787A (ja) 2018-02-27 2020-02-27 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法

Country Status (11)

Country Link
US (2) US20200224160A1 (https=)
EP (1) EP3931322A1 (https=)
JP (2) JP2022521787A (https=)
KR (1) KR20210134000A (https=)
CN (1) CN113906136A (https=)
AU (1) AU2020229848A1 (https=)
CA (1) CA3131588A1 (https=)
IL (1) IL285842A (https=)
MX (1) MX2021010322A (https=)
SG (1) SG11202109332RA (https=)
WO (1) WO2020176740A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
KR20200124702A (ko) 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
US12365888B2 (en) 2018-12-14 2025-07-22 Pioneer Hi-Bred International, Inc. CRISPR-Cas systems for genome editing
SG11202109163YA (en) * 2019-02-26 2021-09-29 Sorrento Therapeutics Inc Antigen binding proteins that bind bcma
AU2020232691B2 (en) 2019-03-05 2023-06-29 Nkarta, Inc. CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
PH12021553076A1 (en) 2019-06-07 2023-08-14 Scribe Therapeutics Inc Engineered casx systems
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
WO2022015956A1 (en) 2020-07-15 2022-01-20 Sorrento Therapeutics, Inc. Improved process for dna integration using rna-guided endonucleases
EP4192941A1 (en) * 2020-08-07 2023-06-14 Neogene Therapeutics B.V. Methods to enrich genetically engineered t cells
CN116829707A (zh) * 2020-11-11 2023-09-29 孟山都技术公司 提高定点整合频率的方法
AU2021392719B2 (en) 2020-12-03 2025-08-14 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
WO2022215978A1 (ko) * 2021-04-05 2022-10-13 주식회사 셀렌진 Pdcd-1 유전자에 상보적인 가이드 rna 및 이의 용도
WO2026020171A2 (en) 2024-07-19 2026-01-22 Aera Therapeutics, Inc. Chimeric antigen receptor constructs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010907A (en) * 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6556674B1 (en) 1998-11-19 2003-04-29 Legerity, Inc. Signal detector with matched filter coefficient
US9957515B2 (en) * 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
WO2014191128A1 (en) * 2013-05-29 2014-12-04 Cellectis Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
WO2017070429A1 (en) * 2015-10-22 2017-04-27 Regents Of The University Of Minnesota Methods involving editing polynucleotides that encode t cell receptor
US11377637B2 (en) * 2016-04-15 2022-07-05 Memorial Sloan Kettering Cancer Center Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
EP4674970A3 (en) * 2016-05-27 2026-03-18 Life Technologies Corporation Compositions and methods for enhancing homologous recombination
WO2018023631A1 (zh) * 2016-08-04 2018-02-08 汤隆初 自动浇水技术的使用情况反馈方法以及自动浇水装置
WO2018073391A1 (en) * 2016-10-19 2018-04-26 Cellectis Targeted gene insertion for improved immune cells therapy
US20200299729A1 (en) * 2017-09-08 2020-09-24 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
WO2019204226A1 (en) * 2018-04-16 2019-10-24 University Of Massachusetts Compositions and methods for improved gene editing

Similar Documents

Publication Publication Date Title
JP7579820B2 (ja) 化学修飾を有するガイドｒｎａ
JP7754721B2 (ja) 標的ｒｎａを編集するための機能性領域を付加したアンチセンス型ガイドｒｎａ
AU2022201038B2 (en) Compositions and methods for promoting homology directed repair
US10526590B2 (en) Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination
KR102738283B1 (ko) 암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분
AU2022271376A1 (en) CRISPR/CAS-related methods and compositions for treating herpes simplex virus
JPWO2019236566A5 (https=)
JP2025013884A5 (https=)
JP2019162140A (ja) Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法
JP2021526853A5 (https=)
EP3748004A1 (en) Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy
JP2025013879A5 (https=)
CA3025523A1 (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules
CN103343120A (zh) 一种小麦基因组定点改造方法
WO2015153791A1 (en) Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2)
EP4399294A1 (en) Guide rnas with chemical modification for prime editing
US12275951B2 (en) Engineered guide RNA and uses thereof
WO2015153789A1 (en) Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)
JPWO2020176740A5 (https=)
JP2015192674A (ja) 多価ｒｎａ干渉のためのポリヌクレオチド、組成物およびそれらの使用方法
JP7641952B2 (ja) 環状一本鎖ポリヌクレオチドを含む核酸送達ベクター
CN104212836A (zh) 一种在哺乳动物细胞系中敲除mir-505的方法
AU2022237663A1 (en) Multiplex editing with cas enzymes
JP2024533448A (ja) 化学修飾を有するガイドｒｎａを使用する方法
JPWO2021217002A5 (https=)